BioSpace News Archive

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, announced financial results for the year ended December 31, 2019.

China’s leading online pharmaceutical network and healthcare service provider is partnering with the Wenjiang People’s Hospital in Chengdu to build an online cancer diagnosis and treatment platform for rare tumors using imported drugs.

Mereo BioPharma Group plc today provided a general business update, including a current assessment of the impact of the coronavirus disease (COVID-19) pandemic on the business. The Company also announced a directorate change. Business Update The Company has provided an update on the setrusumab and alve

On 26 March 2020, the Board of Directors of Nordic Nanovector ASA approved the company’s financial statements for 2019.

Alphamab Oncology (stock code: 9966HK ) announced today that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (“Jiangsu Alphamab”), a wholly-owned subsidiary of the Company, has entered a clinical supply agreement with Pfizer Inc. (“Pfizer”) to advance a clinical study to investigate KN026 in combination with Ibrance® (palbociclib), an

Cognition Therapeutics, Inc. , a clinical-stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced that Kenneth I. Moch has stepped down as president and chief executive officer to assume an advisory role. Lisa Ricciardi has transitioned from her position on the Cognition Board of Directors to become acting chief executive officer. Mr

Investors Double Down on Non-Video Telehealth to Aid Frontline Healthcare Workers in Treating Patients While Focus Turns to Flattening the Curve, Raising Clinical Capacity

Company Offers Support During Pandemic with Childcare Stipend and Supplemental Pay; Plans to Hire 6,000 Additional Caregivers; Maintains Heightened Safety Measures

In response to the COVID-19 pandemic, Priority Health announced further expanded access to home medication deliveries for all its members with the largest pharmacies in the state.